| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |